|1.||Matrisian, Lynn M: 8 articles (08/2009 - 06/2002)|
|2.||Sang, Qing-Xiang Amy: 7 articles (01/2013 - 09/2002)|
|3.||McGuire, John K: 6 articles (04/2014 - 06/2003)|
|4.||Parks, William C: 6 articles (03/2013 - 11/2002)|
|5.||Yamamoto, Hiroyuki: 6 articles (08/2009 - 01/2003)|
|6.||Adachi, Yasushi: 6 articles (08/2009 - 01/2003)|
|7.||Miyazaki, Kaoru: 6 articles (03/2009 - 03/2002)|
|8.||Park, Hyun I: 5 articles (01/2010 - 09/2002)|
|9.||Imai, Kohzoh: 5 articles (08/2009 - 01/2003)|
|10.||Higashi, Shouichi: 5 articles (03/2009 - 11/2003)|
07/01/2002 - "The mean matrilysin labeling index (LI) of gamma-infiltration tumors at the invasive front was significantly greater than that of alpha- and beta-infiltration tumors (P =.01). "
03/01/2004 - "The results of this study indicate that expression of matrix metalloproteinase-7 is related to both the invasiveness of colorectal epithelial tumors and the disturbance of the pit pattern on the tumor surface."
11/01/2001 - "The goal of the current study was to reconcile the proapoptotic and tumor-promoting functions of matrilysin. "
05/01/1998 - "Immunohistochemical study with anti-matrilysin monoclonal antibody revealed that matrilysin was mainly expressed on cancer cells but not or very weakly expressed on other cells. "
07/29/1997 - "In the present study, we analyzed matrilysin-producing cells in various human cancer tissues by immunohistochemistry and in situ hybridization. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
01/01/2012 - "The purpose of this study was to evaluate expression and prognostic value of matrix metalloproteinase-7 (MMP-7) in colorectal cancer (CRC) patients. "
08/01/2003 - "The results of this study suggest that E1AF, the expression of which is closely correlated with the expression of MMP-1 and matrilysin, plays a key role in the progression of colorectal cancer."
02/01/2003 - "The aim of this study was to assess the validity of matrilysin as a prognostic marker of colorectal cancers. "
09/20/2001 - "The aim of our study was to assess the validity of matrilysin as a prognostic marker of colorectal cancers. "
05/18/2001 - "This study was undertaken to clarify the association of matrilysin expression with clinicopathologic parameters in early invasive colorectal carcinomas. "
07/15/1999 - "Patients with matrilysin-positive carcinoma had a significantly shorter disease-free and overall survival time than did those with a matrilysin-negative one (P < 0.0001). "
07/01/2002 - "The aim of this study was to determine whether matrilysin has clinicopathological and prognostic significance in pancreatic carcinoma. "
07/01/2015 - "Matrix metalloproteinase 7 expression in ampullary carcinoma."
01/01/2013 - "Human endometase/matrilysin-2/matrix metalloproteinase-26 (MMP-26) is an endopeptidase mostly produced by human carcinoma cells. "
01/15/2010 - "Endometase (matrilysin 2 or MMP-26) is a putative early biomarker for human carcinomas. "
|4.||Neoplasm Metastasis (Metastasis)
01/01/2015 - "In the present study, we examined the relationship between Reg4 and matrix metalloproteinase-7 (MMP-7) expression in CRC, particularly with regard to metastasis. "
05/30/2015 - "Matrix metalloproteinase-7 (MMP-7) is over-expressed by CRC cells and supposed to play a major role in CRC cell diffusion and metastasis. "
01/01/2014 - "Clinicopathological assessment revealed that higher matrix metalloproteinase-7 expression is associated with deeper invasion (pooled OR = 3.20; 95% CI = 1.14 - 8.96; P = 0.026), higher TNM stage (pooled OR = 3.67; 95% CI = 2.281-5.99; P<0.001), lymph node metastasis (pooled OR = 2.84; 95% CI = 1.89 - 4.25; P<0.001), and distant metastasis (pooled OR = 3.68; 95% CI = 1.85 - 7.29; P<0.001), but not with histological grade. "
06/01/2013 - "High urinary matrix metalloproteinase 7 (MMP 7) levels were previously shown to be correlated with the presence of lymph node metastases. "
05/01/2009 - "Matrix metalloproteinase 7 (MMP-7) is involved in invasion, metastasis, growth, and angiogenesis. "
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/01/2014 - "Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma."
09/01/2011 - "Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley."
12/01/2008 - "In conclusion, active matrix metalloproteinase-7 expression was associated with more aggressive buccal squamous cell carcinomas."
12/01/2008 - "We investigated the expression of active matrix metalloproteinase-7, using tissue microarray, immunohistochemistry, and western blotting, in oral tissues from 24 patients with buccal squamous cell carcinoma, and correlated the findings with clinicopathological features. "
12/01/2008 - "Protein microarrays have shown that matrix metalloproteinase-7 is upregulated in head and neck squamous cell carcinomas, but its role in local tissue invasion is still uncertain. "
|2.||Epidermal Growth Factor Receptor (EGF Receptor)
|4.||Epidermal Growth Factor (EGF)
|7.||Interleukin-1beta (Interleukin 1 beta)
|8.||Epithelial Sodium Channel
|9.||TNF-Related Apoptosis-Inducing Ligand
|10.||TNF-Related Apoptosis-Inducing Ligand Receptors
|1.||Drug Therapy (Chemotherapy)
|4.||Heterologous Transplantation (Xenotransplantation)